首页> 外文OA文献 >Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: Increased duodenal expression of the iron transporter DMT1
【2h】

Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: Increased duodenal expression of the iron transporter DMT1

机译:遗传性血色素沉着症小鼠模型中铁吸收增加的机制:铁转运蛋白DMT1的十二指肠表达增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hereditary hemochromatosis (HH) is a common autosomal recessive disorder characterized by tissue iron deposition secondary to excessive dietary iron absorption. We recently reported that HFE, the protein defective in HH, was physically associated with the transferrin receptor (TfR) in duodenal crypt cells and proposed that mutations in HFE attenuate the uptake of transferrin-bound iron from plasma by duodenal crypt cells, leading to up-regulation of transporters for dietary iron. Here, we tested the hypothesis that HFE−/− mice have increased duodenal expression of the divalent metal transporter (DMT1). By 4 weeks of age, the HFE−/− mice demonstrated iron loading when compared with HFE+/+ littermates, with elevated transferrin saturations (68.4% vs. 49.8%) and elevated liver iron concentrations (985 μg/g vs. 381 μg/g). By using Northern blot analyses, we quantitated duodenal expression of both classes of DMT1 transcripts: one containing an iron responsive element (IRE), called DMT1(IRE), and one containing no IRE, called DMT1(non-IRE). The positive control for DMT1 up-regulation was a murine model of dietary iron deficiency that demonstrated greatly increased levels of duodenal DMT1(IRE) mRNA. HFE−/− mice also demonstrated an increase in duodenal DMT1(IRE) mRNA (average 7.7-fold), despite their elevated transferrin saturation and hepatic iron content. Duodenal expression of DMT1(non-IRE) was not increased, nor was hepatic expression of DMT1 increased. These data support the model for HH in which HFE mutations lead to inappropriately low crypt cell iron, with resultant stabilization of DMT1(IRE) mRNA, up-regulation of DMT1, and increased absorption of dietary iron.
机译:遗传性血色素沉着病(HH)是一种常见的常染色体隐性遗传疾病,其特征是由于膳食铁吸收过多而继发的组织铁沉积。我们最近报道了HFE(HH中的蛋白质缺陷)与十二指肠隐窝细胞中的转铁蛋白受体(TfR)物理相关,并提出HFE中的突变会减弱十二指肠隐窝细胞对血浆中与运铁蛋白结合的铁的吸收,从而导致饮食铁转运蛋白的调节。在这里,我们测试了HFE-/-小鼠增加了二价金属转运蛋白(DMT1)的十二指肠表达的假设。与HFE + / +同窝仔相比,HFE-/-小鼠在4周龄时表现出铁负荷,转铁蛋白饱和度升高(68.4%对49.8%),肝铁浓度升高(985μg/ g对381μg/ G)。通过使用Northern印迹分析,我们定量了DMT1两种转录物的十二指肠表达:一种包含铁反应元件(IRE),称为DMT1(IRE),另一种不包含IRE,物质称为DMT1(non-IRE)。 DMT1上调的阳性对照是一种膳食铁缺乏症的鼠模型,该模型表明十二指肠DMT1(IRE)mRNA的水平大大提高。尽管HFE-/-小鼠的转铁蛋白饱和度和肝铁含量升高,但它们的十二指肠DMT1(IRE)mRNA也有所增加(平均7.7倍)。 DMT1(非IRE)的十二指肠表达没有增加,DMT1的肝脏表达也没有增加。这些数据支持HH模型,其中HFE突变导致不适当的低隐窝细胞铁,从而导致DMT1(IRE)mRNA稳定,DMT1上调,并增加膳食铁的吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号